fda indications for semaglutide 🎉Exciting news that is now approved MASH (aka fatty liver disease) “At week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% Timeline of FDA approvals for

Arora founded Arora Health, the clinical network that provides Trimis medical oversight

In phase 2 clinical trials published in the New England Journal of Medicine in 2023, participants on the highest dose of retatrutide lost an average of 24.2% of their body weight over 48 weeks

We work to ensure that product information is correct

Some patients who experienced libido changes on semaglutide report improvement after switching to tirzepatide, though this is anecdotal rather than evidence-based

Writer Tori Martinet, RD, tested this bra and appreciated the comfortable fit

However, the observational nature of our study limits the availability of variables such as treatment adherence or lifestyle factors, which may contribute to response heterogeneity